June
Investment banker David Williams still going rogue
“We were not aware he would say such things,” the Bionic Institute’s Robert Klupacs wrote in his apology.
- Updated
- Myriam Robin
April
Why picking ASX biotechs is mostly for the crazy brave
It’s a space with a reputation for rollercoaster returns and outlandish sales pitches, but some investors get lucky.
- Tom Richardson
November 2021
PolyNovo’s tumble, CEO’s exit leave room for improvement
The biotech appeared resilient to the headwinds of COVID-19, but the sudden exit of its CEO and more virus waves make the outlook hazy.
- Carrie LaFrenz
August 2021
JBS has Scott Mitchell to soften the blows
Countering any qualms is well-connected ex-Nationals director Scott Mitchell, whose lobbying firm began working for JBS in 2017.
- Myriam Robin
June 2021
Kidder Williams boss adds Tassie farm to rural empire
David Williams has acquired 718 hectares of Derwent River-fronting farmland near Hobart that has potential for viticulture, tourism and residential subdivision.
- Larry Schlesinger
March 2021
Kidder Williams boss beefs up in wagyu
David Williams added another 470 hectares to his rural holding north of Melbourne, which is leased to renowned Wagyu producer David Blackmore.
- Larry Schlesinger
January 2021
PolyNovo says COVID-19 surge slowed US second quarter sales
The biotech says predicting sales trajectory in its key market is "challenging" with hospital capacity strained as COVID-19 cases surge.
- Updated
- Carrie LaFrenz
December 2020
Medical Developments seeks $30m in fresh capital
Gordon Naylor, the incoming chairman of the biotech, says there are parallels with ASX giant CSL, where he worked for three decades.
- Carrie LaFrenz
August 2020
Medical Developments buys back European 'green whistle' rights
The ASX minnow's current distribution partner's parent, Purdue Group, is dealing with numerous legal cases relating to the opioid epidemic in the United States.
- Carrie LaFrenz
April 2020
Polynovo sales surge almost vindicates David Williams' top-ups
Since the results in late February, few days have gone by without Williams increasing his holdings
- Myriam Robin
March 2020
The directors buying into their cratering companies
With trading windows wide open, some insiders have had the cash on hand to buy while the going is cheap.
- Myriam Robin
October 2019
PolyNovo chief can keep share sales quiet
Paul Brennan sold 722,155 shares that year to cover a tax bill, a disposal only revealed in the remuneration report.
- Myriam Robin